An adenosine A2A receptor antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tozadenant

Item No. 28452

Technical Information
Formal Name
4-hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl]-4-methyl-1-piperidinecarboxamide
CAS Number
870070-55-6
Molecular Formula
C19H26N4O4S
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 2 mg/mlDMF:PBS (pH 7.2) (1:4): 0.20 mg/ml
λmax
255, 284 nm
SMILES
COC1=C(N=C(NC(N2CCC(O)(C)CC2)=O)S3)C3=C(N4CCOCC4)C=C1
InChi Code
InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)
InChi Key
XNBRWUQWSKXMPW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Tozadenant is an adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for the human and rhesus monkey receptors, respectively).1 It increases the distance traveled and reduces contralateral asymmetry in the open field test in a rat model of Parkinson's disease induced by 6-OHDA (Item No. 25330) when administered at a dose of 30 mg/kg.2 Tozadenant (150 mg/kg) reverses locomotor deficits and restores novel object-stimulated locomotion in a marmoset model of MPTP-induced Parkinson's disease.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Barret, O., Hannestad, J., Alagille, D., et al. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys. J. Nucl. Med. 55(10), 1712-1718 (2014).

    2. Michel, A., Downey, P., Van Damme, X., et al. Behavioural assessment of the A2a/NR2B combination in the unilateral 6-OHDA-lesioned rat model: A new method to examine the therapeutic potential of non-dopaminergic drugs. PLoS One 10(8), e0135949 (2015).

    3. Michel, A., Nicolas, J.M., Rose, S., et al. Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets. PLoS One 12(8), e0182887 (2017).